Webinar | October 5, 2020

Accelerating Drug Discovery With Artificial Intelligence

With Ton Van Daelen, Portfolio Lead, Scientific Informatics, BIOVIA

It typically takes about 5 years and requires the synthesis of 4,000 or more compounds to develop a new lead candidate. BIOVIA Dassault Systèmes has launched an initiative that leverages AI and machine learning techniques to significantly reduce cost and timelines for discovering new lead candidates while at the same time to increase their success rate in the clinic.

BIOVIA’s Generative Therapeutics Design solution (GTD) helps medicinal chemists decide ‘what to make next’ in an active learning process. The solution combines advanced predictive modeling techniques with automated structure generation, modeling and simulation, and multi-objective optimization. Computational chemists can play an important supporting role integrating in house methods and tailoring these to the needs of the end-user. In this webinar, BIOVIA will present the GTD solution and discuss various customer projects.

VIEW THE WEBINAR!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Drug Discovery Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: